No photo available yet

Agilent Technologies ·Made in USA · In Active Production

Agilent Technologies BL21(DE3) Chemically Competent Cells for protein expression

Agilent Technologies BL21(DE3) Chemically Competent Cells for protein expression — Protein expression.

BL21(DE3) chemically competent cells are a T7 RNA polymerase-based E. coli expression host supplied in a transformation-ready format. The DE3 lysogen carries the T7 polymerase gene under lacUV5 control, so target genes cloned behind a T7 promoter are induced with IPTG. This modification is the standard host for general protein expression; the facts provided do not specify a transformation efficiency for this exact model.

Full specifications

Core Performance & Functional Specifications
Aav Gene Delivery Efficiency 90 %
Aav Maximum Insert Size 3 kb
Adeasy Maximum Insert Size 7.5 kb
Adeasy Xl Gene Delivery Efficiency 90 %
Quikchange Ht Mutational Region 50 AA
Quikchange Lightning Multi Thermocycling Time Reduction 75 %
Surevector Assembly Reaction Time 20 min
Surevector Time To New Vector 1 day
QuikChange HT oligos per reaction mfr 950 oligos
SURE 2 Supercompetent cells transformation efficiency mfr 1 cfu/μg
SURE Electroporation Competent cells transformation efficiency mfr 1 cfu/μg
SURE Competent cells transformation efficiency mfr 5 cfu/μg
ABLE K Competent cells transformation efficiency mfr 5 cfu/μg
TG1 Competent cells transformation efficiency mfr 1 cfu/μg
XL10-Gold Ultracompetent cells transformation efficiency mfr 5 cfu/μg
ElectroTen-Blue Electroporation Competent cells transformation efficiency mfr 3 cfu/μg
SoloPack Gold Supercompetent cells transformation efficiency mfr 1 cfu/μg
SoloPack Gold Competent cells transformation efficiency mfr 1 cfu/μg
XL1-Blue Electroporation Competent cells transformation efficiency mfr 10 cfu/μg
XL2-Blue Ultracompetent cells transformation efficiency mfr 5 cfu/μg
BL21-CodonPlus (DE3)RIPL Competent cells transformation efficiency mfr 1 cfu/μg
Transformation efficiency mfr 1
ABLE K Strain mfr 15
BL21 Strain mfr E. coli B F– dcm ompT hsdS gal gal
BL21(DE3) Strain mfr E. coli B F– dcm ompT hsdS gal λ
BL21(DE3)pLysS Strain mfr E. coli B F– dcm ompT hsdS gal λ [pLysS Camr]*
BL21-CodonPlus (DE3)-RIPL Strain mfr E. coli B F– ompT hsdS dcm+ Tetr gal λ endA Hte
ElectroTen-Blue Strain mfr 183
JM101 Strain mfr -1
JM109 Strain mfr 14
JM110 Strain mfr -1
SCS1 Strain mfr 1
SCS110 Strain mfr -1
TG1 Strain mfr -1
XL1-Blue Strain mfr 1
XL1-Blue MR Strain mfr 183 lac
XL1-Blue MRF' Strain mfr 183
XL2-Blue Strain mfr 1
XL2-Blue MRF' Strain mfr 183
XL1-Red Strain mfr 1
Subcloning-grade transformation efficiency mfr 1 ransformants/μg
Competent cell transformation efficiency mfr 1 ransformants/μg
Supercompetent cell transformation efficiency mfr 1 ransformants/μg
Ultracompetent cell transformation efficiency mfr 5 ransformants/μg
Electroporation-competent cell transformation efficiency mfr 1 ransformants/μg
ElectroTen-Blue transformation efficiency mfr 3.0
SURE electroporation-competent transformation efficiency mfr 1 DNA
SURE competent-grade transformation efficiency mfr 5 DNA
SURE2 supercompetent transformation efficiency mfr 1 DNA
ABLE K plasmid copy number reduction mfr 10 fold
XL1-Red mutation rate increase mfr 5000 higher
Electrical, Power & Drive Specifications
BL21-Gold Starin mfr E. coli B F– dcm+ Hte ompT hsdS gal endA Tetr a
BL21-Gold(DE3) Strain mfr E. coli B F– dcm+ Hte ompT hsdS gal λ endA Tetr
BL21-Gold(DE3)pLysS Strain mfr E. coli B F– dcm+ Hte ompT hsdS gal λ [pLysS Cam
BL21-CodonPlus RIL Strain mfr E. coli B F– ompT hsdS dcm+ Tetr gal endA Hte [a
BL21-CodonPlus(DE3)-RIL Strain mfr E. coli B F– ompT hsdS dcm+ Tetr gal λ endA Hte
BL21-CodonPlus (DE3)-RP Strain mfr E. coli B F– ompT hsdS dcm+ Tetr gal λ endA Hte
Standards, Safety & General Data
Standard Transfection Gene Delivery Efficiency 20 %

Description

Construction and series positioning

Behaviour and use

Handling and operation

Integration & Operating Notes

Process Limits
Target gene must sit behind a T7 promoter for expression

The DE3 lysogen supplies T7 RNA polymerase under lacUV5 control, so only constructs with a T7 promoter are transcribed by this host; genes on other promoters will not be expressed through the T7 route and require a different host or promoter design.

Agilent competent cells brochure 5989-8281EN, BL21(DE3) line description
Process Limits
Induction requires IPTG addition at the chosen point

Expression is triggered by IPTG, which is listed in the portfolio as an accessory rather than part of the base cell delivery; plan to source IPTG separately and to define the induction point in your protocol, since the supplied digests give no induction parameters.

Agilent competent cells brochure 5989-8281EN, accessory listing (AMP Tabs and IPTG
Maintenance
Follow the product-specific protocol; brochures carry no protocol

The attached documents are portfolio leaflets with no transformation, heat-shock, recovery or storage instructions. Obtain the lot-specific protocol for this model before first use, because the digests provide no actionable handling facts to rely on.

Synthetic Bio Brochure 5991-9163EN; Agilent competent cells brochure 5989-8281EN
Process Limits
Do not apply the unlabeled 5 cfu/µg figure to this model

The extra specification list contains an unlabeled transformation efficiency value of 5 alongside many strain-specific entries. No efficiency is verified for BL21(DE3) itself, so qualification of a lot should be based on the certificate supplied with the cells, not on that table.

Factory Specification Sheet (extra specs

Selection & Integration Q&A

When should I choose BL21(DE3) rather than the BL21-Gold or BL21-CodonPlus variants in the same portfolio?

Pick base BL21(DE3) for routine T7-driven expression when no rare-codon supplementation or extra stringency is needed. BL21-CodonPlus (RIL/RP/RIPL) adds rare tRNAs for codon-biased genes; pLysS derivatives add tighter control of basal T7 expression. The supplied facts give no efficiency data to rank them numerically.

What must my expression construct and induction setup provide to work with this host?

The gene must be cloned downstream of a T7 promoter, since the DE3 lysogen supplies T7 polymerase under lacUV5 control. IPTG is required for induction and is listed as a separate accessory, not part of the base cell delivery, so it must be sourced and its addition point defined in your protocol.

What handling and storage conditions does the documentation specify for these cells?

The attached brochures are portfolio-level leaflets and contain no transformation, heat-shock, recovery or storage temperatures for this model. The lot-specific product protocol must be obtained and followed; no handling limits can be quoted from the supplied digests.

What is not included with the base cells and what should be ordered alongside?

IPTG and AMP Tabs appear in the portfolio as accessories rather than base-delivery items, so induction and selection reagents should be ordered separately. No transformation-efficiency value is verified for this exact model, so lot qualification should rely on the supplied certificate.

Dimensional Drawings & Technical Documentation

Technical documentation

PDF
Competent Cells
Brochure ·2,0 МБ ·20 pp.
View PDF